Humana (HUM) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
Humana Inc. (HUM) insider buying and selling: 1 purchase, no sales
56 Form 4 Table I transactions filed with the SEC by Humana Inc. insiders between 2025-10-03 and 2026-09-03 (15-month history): 1 open-market purchase and 0 sales, plus 55 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a purchase of $150k by Shetty Sanjay K on 2026-02-23.
Humana insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, Humana insiders filed 1 purchase worth $150k on the open market, and no sales.
The largest trade of the period was a purchase of $150k on Feb 23, 2026, by Shetty Sanjay K (President, CenterWell). Form 4 on sec.gov (0001969331-26-000002).
The latest purchase is from Feb 23, 2026.
Against its sector (Healthcare, 59 companies with an insider page on this site), over the same dates the median is 9 sales and 0 purchases on the open market. Humana has no sales, like 4 of the other 58, ranks 6 of 59 by net dollars bought, and 19 of the 59 have at least one purchase, Humana included.
The 20 most important trades
The only open-market purchase first, then the rest, each type from largest to smallest. The full history is in the tool above, already searched.
See all 56 HUM trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-02-23 | 2026-02-25 | Shetty Sanjay K | President, CenterWell | $150k | P — Open-market purchase2 Form 4 footnotesF4 Shares purchased on open market at reported price. F3 Includes 8,818 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2025-12-15 | 2025-12-17 | Rechtin James A. | President & CEO | $911k | F — Tax withholding (shares surrendered for taxes) Indirect holding, through: See Footnote 3 Form 4 footnotesF7 Shares disposed of represent payment of tax liability for shares vesting on 12/15/25. No value was received in return. F6 Includes 14,054 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. | SEC |
| 2026-02-13 | 2026-02-18 | Mellet Celeste | Chief Financial Officer | $763k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF2 Shares disposed of represent payment of tax liability for shares vesting 2/13/26 in which no value was received in return. F1 Includes 19,785 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2025-12-15 | 2025-12-17 | Mellet Celeste | Chief Financial Officer | $330k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF2 Shares disposed of represent payment of tax liability for shares vesting 12/15/25 in which no value was received in return. F1 Includes 27,548 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2025-12-15 | 2025-12-17 | Ventura Joseph C | Chief Legal Officer | $296k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF10 Shares disposed of represent payment for tax liability on shares vesting vested on 12/15/25. No value was received in return. F9 Includes 6,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2026-01-01 | 2026-01-05 | O'Hara Michelle A. | Chief Human Resources Officer | $283k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF2 Shares disposed of represent payment of tax liability for shares vesting on 1/1/26. No value was received in return. F1 Includes 7,512 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(l)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2025-12-15 | 2025-12-17 | Shetty Sanjay K | President, CenterWell | $277k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF6 Shares disposed of represent payment of tax liability for shares vesting 12/15/25. No value was received in return. F5 Includes 8,818 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2026-01-08 | 2026-01-12 | Rechtin James A. | President & CEO | $274k | F — Tax withholding (shares surrendered for taxes) Indirect holding, through: See Footnote 3 Form 4 footnotesF7 Shares disposed of represent payment of tax liability for shares vesting on 1/8/26. No value was received in return. F6 Includes 14,054 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. | SEC |
| 2025-12-15 | 2025-12-17 | Renaudin George Ii | President, Insurance | $263k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF8 Shares disposed of represent payment for tax liability on restricted stock vesting on 12/15/25. No value was received in return. F6 Includes 9,059 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2025-12-15 | 2025-12-17 | Dintenfass David | President, Enterprise Growth | $248k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF3 Shares disposed of represent payment for tax liability on restricted stock units vested on 12/15/25. F2 Includes 11,202 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2026-02-21 | 2026-02-24 | Dintenfass David | President, Enterprise Growth | $224k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF3 Shares disposed of represent payment for tax liability on restricted stock units vested on 2/21/26. F2 Includes 7,344 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2025-12-15 | 2025-12-17 | O'Hara Michelle A. | Chief Human Resources Officer | $171k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF2 Shares disposed of represent payment of tax liability for shares vesting on 12/15/25. No value was received in return. F1 Includes 9,865 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(l)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2025-12-15 | 2025-12-17 | Mehta Japan | Chief Information Officer | $127k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF2 Shares disposed of represent payment of tax liability for shares vesting on 12/15/25. No value was received in return. F1 Includes 7,434 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2026-02-24 | 2026-02-26 | Ventura Joseph C | Chief Legal Officer | $85k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF9 Shares disposed of represent payment for tax liability on performance stock units vested on 2/24/26. No value was received in return. F7 Includes 6,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2026-02-13 | 2026-02-18 | Mehta Japan | Chief Information Officer | $78k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF2 Shares disposed of represent payment of tax liability for shares vesting on 2/13/26. No value was received in return. F1 Includes 5,752 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2026-02-24 | 2026-02-26 | Renaudin George Ii | President, Insurance | $74k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF7 Shares disposed of represent payment for tax liability on performance stock vesting on 2/24/26. No value was received in return. F4 Includes 9,059 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2025-12-15 | 2025-12-17 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | $71k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF4 Shares disposed of represent payment for tax liability on restricted stock vesting 12/15/25. No value was received in return. F3 Includes 748 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2026-04-01 | 2026-04-03 | Shetty Sanjay K | President, CenterWell | $70k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF5 Shares withheld for payment of tax liability on performance stock vesting on 4/1/26. No value was received in return. F3 Includes 8,818 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
| 2025-10-01 | 2025-10-03 | Renaudin George Ii | President, Insurance | $61k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF9 Shares disposed of represent payment for tax liability on restricted stock vesting on 10/1/25. No value was received in return. | SEC |
| 2026-02-24 | 2026-02-25 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | $15k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF3 Shares disposed of represent payment for tax liability on performance stock units vesting 2/24/26. No value was received in return. F1 Includes 6,417 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | SEC |
The period balance: money in, money out
In the Form 4 filings submitted between Oct 3, 2025 and Sep 3, 2026 there is not one open-market sale of Humana Inc.: 1 open-market purchase worth $150k and zero dollars sold.
Only codes P and S count, where an insider puts in or takes out their own money. A buying balance like Humana Inc.'s is the less common case in the S&P 500: its insiders are already paid in stock and still put in their own money. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| M | Option exercise | 20 | $0 |
| F | Tax withholding (shares surrendered for taxes) | 19 | $4.6M |
| A | Grant or award | 16 | $0 |
| P | Open-market purchase | 1 | $150k |
| Total | Everything filed in the period | 56 | $4.8M |
36 of the 56 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 17 distinct people or entities have filed Humana Inc. transactions: 1 bought on the open market and none sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Shetty Sanjay K | President, CenterWell | 6 | $150k (1) | — | 2026-05-05 |
| Renaudin George Ii | President, Insurance | 6 | — | — | 2026-02-26 |
| Dintenfass David | President, Enterprise Growth | 5 | — | — | 2026-05-05 |
| Felter John-Paul W. | SVP, Chief Accting Off & Cont. | 5 | — | — | 2026-02-25 |
| Mehta Japan | Chief Information Officer | 5 | — | — | 2026-05-05 |
| Mellet Celeste | Chief Financial Officer | 5 | — | — | 2026-05-05 |
| O'Hara Michelle A. | Chief Human Resources Officer | 5 | — | — | 2026-05-05 |
| Rechtin James A. | President & CEO | 5 | — | — | 2026-05-05 |
Shown here are the 8 who moved the most money, out of 17. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
Across the 15 months of history there is only 1 open-market trade in Humana Inc., so no calendar is published: 15 rows of zeros would fake a pattern where there is no sample to read. It is listed with its date in the tables above.
Humana Inc. (HUM) analysis page →
Other Healthcare companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
Humana's single open-market purchase (code P) is the rare signal: insiders are already paid in stock, so buying more means putting in their own money. The latest filing is from Sep 3, 2026, and a Form 4 arrives up to two business days after the trade.
20 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.